Phase III trial of daily ZP-PTH in patients with osteoporosis

Trial Profile

Phase III trial of daily ZP-PTH in patients with osteoporosis

Planning
Phase of Trial: Phase III

Latest Information Update: 30 Mar 2015

At a glance

  • Drugs Teriparatide (Primary)
  • Indications Osteoporosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Mar 2015 New trial record
    • 25 Mar 2015 The company expects to confirm the trial design with regulatory authorities by end of 2015, according to Zosano Pharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top